EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides Enhances mRNA Efficacy via Reduced Endosomal Retention

Yuxin He, Lin Wang iD, Abigael P Williams iD, Trisha I Valerio, Yuanhong Sun, James Bowman, Samantha D Ricketts, Savannah Hammond, Aidan Sison, Jezan Alexandre, Zachary Niastor, Wei R Chen und 4 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.6c11865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Yuxin He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma73019, United States. Hauptthemen laut MEDLINE: Nanoparticles, Endosomes, RNA, Messenger, Polysaccharides. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health (NIH), NIGMS NIH HHS, Oklahoma Center for Adult Stem Cell Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we developed a library of mRNA lipid nanoparticles (LNPs) containing clinically used ionizable lipids. We surface-modified these nanoparticles with heparosan polysaccharides and systematically compared their performance with conventional poly(ethylene glycol) (PEG)-modified formulations. Our heparosan (HEP)-coated LNPs increased mRNA expression in dendritic and macrophage cell lines by up to ∼10-fold. Mechanistic studies using live-cell imaging and intracellular nanoparticle trafficking analysis revealed that HEP-modified LNPs exhibited reduced colocalization with late endosomal (Rab7+) and lysosomal (LAMP1+) compartments. These findings are consistent with enhanced endosomal escape of HEP-modified formulations. Repeated subcutaneous administrations of HEP-modified firefly luciferase mRNA-LNPs demonstrated sustained expression and distinct response dynamics in mice. We further observed significantly enhanced humoral anti-spike protein immune responses in mice after subcutaneous administration of HEP-modified LNPs containing SARS-CoV-2 spike S-2P mRNA. Histopathological evaluation and spleen immune cell profiling showed no observable toxicity or adverse effects. Overall, these results demonstrate the effects of HEP surface modification on mRNA LNP expression, intracellular trafficking, and in vivo activity, and support HEP-based surface engineering as a PEG-free approach for nucleic acid delivery and potential future applications in nanomedicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesEndosomesRNA, MessengerPolysaccharidesLipidsAnimalsMiceHumansFemalePolyethylene GlycolsSARS-CoV-2Surface PropertiesCOVID-19DisaccharidesLiposomes

Stichwörter der Autor:innen

Lipid nanoparticlesPEG-freeendosomal escapeheparosan polysaccharidesmRNA deliverynanomedicinenanoparticle surface engineering

Substanzen

RNA, MessengerPolysaccharidesheparosanLipidsLipid NanoparticlesPolyethylene GlycolsDisaccharidesLiposomes

Autor:innen und Institutionen

  • Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma73019, United States.
  • Department of Pathology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma73104, United States.
  • Department of Biochemistry and Physiology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma73104, United States.
  • Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma73104, United States.
  • Institute for Biomedical Engineering, Science, and Technology (IBEST), University of Oklahoma, Norman, Oklahoma73019, United States.
  • Harold Hamm Diabetes Center, University of Oklahoma, Oklahoma City, Oklahoma73104, United States.

ORCID-Profile: Lin Wang, Abigael P Williams, Stefan Wilhelm

Förderung

  • National Institutes of Health (NIH)
  • NIGMS NIH HHS
  • Oklahoma Center for Adult Stem Cell Research
  • Presbyterian Health Foundation
  • NCI NIH HHS
  • National Science Foundation (NSF)
  • University of Oklahoma

Zitieren

APA

He, Y., Wang, L., Williams, A. P., Valerio, T. I., Sun, Y., Bowman, J., Ricketts, S. D., Hammond, S., Sison, A., Alexandre, J., Niastor, Z., Chen, W. R., Green, D. E., Fung, K. M., DeAngelis, P. L., & Wilhelm, S. (2026). Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides Enhances mRNA Efficacy via Reduced Endosomal Retention. ACS Nano. https://doi.org/10.1021/acsnano.6c11865

Vancouver

He Y, Wang L, Williams AP, Valerio TI, Sun Y, Bowman J, et al. Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides Enhances mRNA Efficacy via Reduced Endosomal Retention. ACS Nano. 2026. doi:10.1021/acsnano.6c11865

BibTeX
@article{He2026,
  author = {He, Yuxin and Wang, Lin and Williams, Abigael P and Valerio, Trisha I and Sun, Yuanhong and Bowman, James and Ricketts, Samantha D and Hammond, Savannah and Sison, Aidan and Alexandre, Jezan and Niastor, Zachary and Chen, Wei R and Green, Dixy E and Fung, Kar-Ming and DeAngelis, Paul L and Wilhelm, Stefan},
  title = {Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides Enhances mRNA Efficacy via Reduced Endosomal Retention},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c11865}
}
Kostenlos starten →